Andrew Akampurira

Kampala, C, Uganda

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Cryptococcus neoformans responds to presence of Mycobacterium by diversifying its morphologies and remodelling its capsular material.

Cryptococcus neoformans responds to presence of Mycobacterium by diversifying its morphologies and remodelling its capsular material.

Journal: Journal of medical microbiology
Published: February 23, 2026

Analytical validation: Comparison of two laboratory-based methods for CSF quantitative cryptococcal cultures.

Analytical validation: Comparison of two laboratory-based methods for CSF quantitative cryptococcal cultures.

Journal: Medical mycology
Published: September 21, 2025

The evolution of HIV-associated cryptococcal meningitis in Uganda from 2010 to 2022.

The evolution of HIV-associated cryptococcal meningitis in Uganda from 2010 to 2022.

Journal: Medical mycology
Published: September 09, 2024

Impact of cerebrospinal fluid leukocyte infiltration and activated neuroimmune mediators on survival with HIV-associated cryptococcal meningitis.

Impact of cerebrospinal fluid leukocyte infiltration and activated neuroimmune mediators on survival with HIV-associated cryptococcal meningitis.

Journal: PLoS neglected tropical diseases
Published: June 30, 2024

Extracellular hydrolytic enzyme activities and biofilm formation in Candida species isolated from people living with human immunodeficiency virus with oropharyngeal candidiasis at HIV/AIDS clinics in Uganda.

Extracellular hydrolytic enzyme activities and biofilm formation in Candida species isolated from people living with human immunodeficiency virus with oropharyngeal candidiasis at HIV/AIDS clinics in Uganda.

Journal: Microbial pathogenesis
Published: June 20, 2024

Impact of Cerebrospinal Fluid Leukocyte Infiltration and Neuroimmmune Mediators on Survival with HIV-Associated Cryptococcal Meningitis.

Impact of Cerebrospinal Fluid Leukocyte Infiltration and Neuroimmmune Mediators on Survival with HIV-Associated Cryptococcal Meningitis.

Journal: medRxiv : the preprint server for health sciences
Published: June 10, 2024

In Vitro Evaluation of the Virulence Attributes of Oropharyngeal Candida Species Isolated from People Living with Human Immunodeficiency Virus with Oropharyngeal Candidiasis on Antiretroviral Therapy.

In Vitro Evaluation of the Virulence Attributes of Oropharyngeal Candida Species Isolated from People Living with Human Immunodeficiency Virus with Oropharyngeal Candidiasis on Antiretroviral Therapy.

Journal: Research square
Published: May 20, 2024

Evolution of Laboratory Diagnostics for Cryptococcosis and Missing Links to Optimize Diagnosis and Outcomes in Resource-Constrained Settings.

Evolution of Laboratory Diagnostics for Cryptococcosis and Missing Links to Optimize Diagnosis and Outcomes in Resource-Constrained Settings.

Journal: Open forum infectious diseases
Published: May 03, 2024

5-Flucytosine Longitudinal Antifungal Susceptibility Testing of Cryptococcus neoformans: A Substudy of the EnACT Trial Testing Oral Amphotericin.

5-Flucytosine Longitudinal Antifungal Susceptibility Testing of Cryptococcus neoformans: A Substudy of the EnACT Trial Testing Oral Amphotericin.

Journal: Open forum infectious diseases
Published: August 31, 2023

Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial.

Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 08, 2023

Sterile Cerebrospinal Fluid Culture at Cryptococcal Meningitis Diagnosis Is Associated with High Mortality.

Sterile Cerebrospinal Fluid Culture at Cryptococcal Meningitis Diagnosis Is Associated with High Mortality.

Journal: Journal of fungi (Basel, Switzerland)
Published: October 20, 2022

ATI-2307 Exhibits Equivalent Antifungal Activity in Cryptococcus neoformans Clinical Isolates With High and Low Fluconazole IC50.

ATI-2307 Exhibits Equivalent Antifungal Activity in Cryptococcus neoformans Clinical Isolates With High and Low Fluconazole IC50.

Journal: Frontiers in cellular and infection microbiology
Published: April 14, 2021
Showing 1-12 of 28

Last Updated: 09/26/2026